Implications to payers of switch from hospital-based intravenous immunoglobulin (IVIg) to home-based subcutaneous immunoglobulin (SCIg) therapy in patients with primary immunodeficiencies (PID) and secondary immunodeficiencies (SID) in Canada

机译：加拿大原发性免疫缺陷（PID）和继发性免疫缺陷（SID）患者从医院静脉内免疫球蛋白（IVIg）转向家庭皮下免疫球蛋白（SCIg）治疗对付款人的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Allergy Asthma and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
作者
William C Gerth; Stephen D Betschel; Arthur S Zbrozek;
展开▼
作者单位

展开▼
年(卷),期 2014(10),Suppl 1
年度 2014
页码 A42
总页数 2
原文格式 PDF
正文语种
中图分类免疫学;
关键词

相似文献

外文文献
中文文献

1. Treatment costs associated with hospital-based intravenous immunoglobulin therapy compared to home-based subcutaneous immunoglobulin therapy in a cohort of paediatric patients with primary immunodeficiency [J] . Thierry Ducruet, Marie-Claude Levasseur, Anne Des Roches, Allergy, Asthma & Clinical Immunology . 2011,第SUPPLEMENTa2期

机译：与基于家庭的皮下免疫球蛋白治疗相比，基于医院的静脉内免疫球蛋白治疗相关的治疗费用在一组患有原发性免疫缺陷的儿科患者中
2. Evaluating Dose Ratio of Subcutaneous to Intravenous Immunoglobulin Therapy Among Patients With Primary Immunodeficiency Disease Switching to 20% Subcutaneous Immunoglobulin Therapy [J] . Krishnarajah Girishanthy, Lehmann Jee-Yeon K., Ellman Brian, The American journal of managed care . 2016,第15Suppla期

机译：评价原发性免疫缺陷疾病患者转皮下免疫球蛋白治疗比例为20％的患者皮下与静脉免疫球蛋白治疗的剂量比
3. Efficacy and Safety of Hospital-Based Intravenous Immunoglobulin and Home-Based Self-Administered Subcutaneous Immunoglobulin in Polish Children with Primary Immunodeficiency Diseases [J] . Bal Katarzyna, Kaluzinska-Parzyszek Izabela, Sobocinska Agnieszka, Indian journal of pediatrics . 2015,第8期

机译：波兰原发性免疫缺陷病患儿基于医院的静脉免疫球蛋白和家庭自用皮下免疫球蛋白的疗效和安全性
4. Standards of treatment with subcutaneous immunoglobulins in primary immunodeficiencies –guidelines for doctors and nurses drawn up by three immunology centers in Poland. [C] . Lewowicz-Uszyńska A., Szaflarska A., Pietrucha B., European Society Immunodeficiencies., Meeting. . 2013

机译：初级免疫植物中皮下免疫球蛋白的治疗标准 - 在波兰三次免疫中心制定的医生和护士。
5. Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada [O] . William C Gerth, Stephen D Betschel, Arthur S Zbrozek 2014

机译：对加拿大原发性和继发性免疫缺陷患者从医院静脉内免疫球蛋白转向家庭皮下免疫球蛋白治疗的意义
6. Implications to payers of switch from hospital-based intravenous immunoglobulin (IVIg) to home-based subcutaneous immunoglobulin (SCIg) therapy in patients with primary immunodeficiencies (PID) and secondary immunodeficiencies (SID) in Canada [O] . William C Gerth, Stephen D Betschel, Arthur S Zbrozek 2014

机译：加拿大原发性免疫缺陷（PID）和继发性免疫缺陷（SID）患者从医院静脉内免疫球蛋白（IVIg）转向家庭皮下免疫球蛋白（SCIg）治疗对付款人的影响

Implications to payers of switch from hospital-based intravenous immunoglobulin (IVIg) to home-based subcutaneous immunoglobulin (SCIg) therapy in patients with primary immunodeficiencies (PID) and secondary immunodeficiencies (SID) in Canada

著录项

相似文献

相关主题

期刊订阅